LBPMedicine(SH:688393) Sou Hu Cai Jing·2025-08-07 11:45Company Overview - Anbiping's closing price on August 7 was 33.34 yuan, with an increase of 1.18%, resulting in a rolling PE ratio of 1394.21 times, the lowest in 86 days, and a total market capitalization of 3.12 billion yuan [1] - The company's main business includes tumor screening and diagnostic reagents, automation equipment, and auxiliary diagnostic artificial intelligence software [1] Financial Performance - In the first quarter of 2025, Anbiping reported operating revenue of 72.54 million yuan, a year-on-year decrease of 28.51%, and a net loss of approximately 11.06 million yuan, a year-on-year decline of 238.49%, with a gross profit margin of 61.97% [1] Shareholder Information - As of March 31, 2025, Anbiping had 10,309 shareholders, an increase of 4,393 from the previous count, with an average holding value of 352,800 yuan and an average holding quantity of 27,600 shares [1] Industry Comparison - The average PE ratio for the medical device industry is 54.79 times, with a median of 37.86 times, placing Anbiping at the 123rd position in the industry ranking [1][2] - Other companies in the industry have significantly lower PE ratios, with the highest being 20.27 times for Sanxin Medical, indicating a substantial disparity compared to Anbiping [2]